Last reviewed · How we verify

NCT06549543

High-Intensity Laser Therapy: Effectiveness on Knee Osteoarthritis Patients

Completed NA Last updated 13 August 2024
What this trial tests

NA trial testing High Intensity Laser Therapy in Osteoarthritis, Knee in 43 participants. Completed in 1 February 2024.

Timeline
1 April 2022
Primary endpoint
30 November 2023
1 February 2024

Quick facts

Lead sponsorBaskent University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment43
Start date1 April 2022
Primary completion30 November 2023
Estimated completion1 February 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 40 to 65, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this prospective, randomized, double-blinded study is to investigate the additional benefits of high-intensity laser therapy (HILT) over conventional physiotherapy, related to pain and function, in patients with knee osteoarthritis (KOA).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Additional effect of high-intensity laser therapy with conventional physiotherapy related to pain and function in patients with knee osteoarthritis: a randomized, double-blind, placebo-controlled, 12-week follow-up study.
    Özgözen S, Özgözen AL, Analan PD, İncekaş C. · · 2025 · PMID 40481859 · DOI 10.1007/s10103-025-04516-6

Verify or expand the search:

Other trials of High Intensity Laser Therapy

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06549543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing